Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HSTM
|
Michael Manning Collier
Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 8,033 Added 13.51% |
-
|
Mar 28
2025 |
|
HSTM
|
Jeff Cunningham
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,597 Reduced 4.7% |
$50,944
$31.9 p/Share
|
Mar 28
2025 |
|
HSTM
|
Jeff Cunningham
Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,556 Added 16.19% |
-
|
Mar 28
2025 |
|
CRI
|
Jevin Eagle
Director |
BUY
Grant, award, or other acquisition
|
Direct | 32 Added 0.17% |
-
|
Mar 28
2025 |
|
HSTM
|
William Stead
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,149 Added 2.6% |
-
|
Mar 28
2025 |
|
CRI
|
Hali Borenstein
Director |
BUY
Grant, award, or other acquisition
|
Direct | 32 Added 0.25% |
-
|
Mar 28
2025 |
|
HSTM
|
Jeffrey L Mclaren
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,149 Added 5.32% |
-
|
Mar 28
2025 |
|
HSTM
|
Terry Allison Rappuhn
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,329 Added 20.64% |
-
|
Mar 28
2025 |
|
HSTM
|
Linda Rebrovick
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,149 Added 2.01% |
-
|
Mar 28
2025 |
|
HSTM
|
Tate Deborah Taylor
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,149 Added 4.84% |
-
|
Mar 28
2025 |
|
HSTM
|
Thompson Dent
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,149 Added 0.85% |
-
|
Mar 28
2025 |
|
HSTM
|
Frank Gordon
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,149 Added 0.55% |
-
|
Mar 28
2025 |
|
VNCE
|
Yuji Okumura
Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 25.95% |
-
|
Mar 28
2025 |
|
CNO
|
Yvonne K Franzese
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 2,013 Reduced 6.94% |
$84,908
$42.18 p/Share
|
Mar 28
2025 |
|
TOL
|
Christine Garvey
Director |
SELL
Bona fide gift
|
Indirect | 47 Reduced 0.0% |
-
|
Mar 28
2025 |
|
BLDE
|
Melissa M. Tomkiel
President and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 27,777 Added 2.17% |
$4,999
$0.18 p/Share
|
Mar 28
2025 |
|
CFFN
|
Jeffrey M Johnson
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 8.14% |
$56,300
$5.63 p/Share
|
Mar 28
2025 |
|
BDC
|
Hiran Bhadra
SVP, Strategy & Technology |
BUY
Grant, award, or other acquisition
|
Direct | 5,548 Added 17.64% |
-
|
Mar 28
2025 |
|
APHP
|
Bannor Michael Mac Gregor
CEO |
SELL
Open market or private sale
|
Indirect | 588,000 Reduced 0.0% |
$76,440
$0.13 p/Share
|
Mar 28
2025 |
|
TDOC
|
Adam C Vandervoort
CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct | 4,418 Added 7.27% |
-
|
Mar 28
2025 |
|
LRCX
|
Timothy Archer
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 8,111 Reduced 0.82% |
$622,438
$76.74 p/Share
|
Mar 28
2025 |
|
LRCX
|
Douglas R Bettinger
Chief Financial Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 2,186 Reduced 0.21% |
$167,753
$76.74 p/Share
|
Mar 28
2025 |
|
MC
|
Louise Mirrer |
BUY
Grant, award, or other acquisition
|
Direct | 13 Added 1.05% |
-
|
Mar 27
2025 |
|
MC
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct | 1 Added 0.81% |
-
|
Mar 27
2025 |
|
MC
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct | 22 Added 1.04% |
-
|
Mar 27
2025 |
|
MC
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct | 28 Added 1.05% |
-
|
Mar 27
2025 |
|
MC
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct | 5 Added 0.91% |
-
|
Mar 27
2025 |
|
MC
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct | 21 Added 1.04% |
-
|
Mar 27
2025 |
|
MC
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct | 27 Added 1.06% |
-
|
Mar 27
2025 |
|
ALCC
|
Caroline Cochran
Co-Founder, COO |
SELL
Open market or private sale
|
Indirect | 35,365 Reduced 0.0% |
$893,673
$25.27 p/Share
|
Mar 27
2025 |
|
ALCC
|
Jacob De Witte
Co-Founder, CEO |
SELL
Open market or private sale
|
Direct | 35,365 Reduced 0.32% |
$893,673
$25.27 p/Share
|
Mar 27
2025 |
|
ALCC
|
John M Jansen
Director |
BUY
Open market or private purchase
|
Direct | 6,000 Added 50.0% |
$147,420
$24.57 p/Share
|
Mar 27
2025 |
|
AEVA
|
Sylebra Capital LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,157,742 Added 0.0% |
$7,120,113
$6.15 p/Share
|
Mar 27
2025 |
|
UVE
|
Sean P Downes
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 8,342 Added 0.83% |
-
|
Mar 27
2025 |
|
UVE
|
Sean P Downes
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 3,283 Reduced 0.33% |
$75,016
$22.85 p/Share
|
Mar 27
2025 |
|
UVE
|
Frank Wilcox
CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,503 Added 1.83% |
-
|
Mar 27
2025 |
|
UVE
|
Frank Wilcox
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 610 Reduced 0.46% |
$13,938
$22.85 p/Share
|
Mar 27
2025 |
|
UVE
|
Stephen Donaghy
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 14,598 Added 2.0% |
-
|
Mar 27
2025 |
|
UVE
|
Stephen Donaghy
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 5,745 Reduced 0.8% |
$131,273
$22.85 p/Share
|
Mar 27
2025 |
|
UVE
|
Kimberly D Campos
CIO & CAO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,252 Added 11.28% |
-
|
Mar 27
2025 |
|
UVE
|
Kimberly D Campos
CIO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 305 Reduced 3.1% |
$6,969
$22.85 p/Share
|
Mar 27
2025 |
|
FTV
|
Wright Lassiter Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2 Added 0.02% |
$149
$74.82 p/Share
|
Mar 27
2025 |
|
IMRA
|
Benjamin Hohl
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 3,250 Reduced 12.38% |
$69,322
$21.33 p/Share
|
Mar 27
2025 |
|
IMRA
|
Benjamin Hohl
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 3,250 Added 11.02% |
$8,060
$2.48 p/Share
|
Mar 27
2025 |
|
SLNO
|
James H Mackaness
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 70,000 Added 28.55% |
$645,400
$9.22 p/Share
|
Mar 27
2025 |
|
SLNO
|
James H Mackaness
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 90,622 Reduced 46.28% |
$6,294,604
$69.46 p/Share
|
Mar 27
2025 |
|
SLNO
|
Meredith Manning
Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 37,000 Added 31.0% |
$1,713,470
$46.31 p/Share
|
Mar 27
2025 |
|
SLNO
|
Meredith Manning
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 45,249 Reduced 49.94% |
$3,123,538
$69.03 p/Share
|
Mar 27
2025 |
|
SLNO
|
Kristen Yen |
BUY
Exercise of conversion of derivative security
|
Direct | 40,638 Added 28.54% |
$172,711
$4.25 p/Share
|
Mar 27
2025 |
|
SLNO
|
Kristen Yen |
SELL
Open market or private sale
|
Direct | 95,500 Reduced 77.24% |
$6,561,804
$68.71 p/Share
|
Mar 27
2025 |